Davor M.
- Country
- Croatia
- Department
- Cardiology
Research Overview
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients
- Evaluation of Vutrisiran Efficacy and Safety in Transthyretin Amyloidosis with Cardiomyopathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 232 of 802 partner sites.
Specializations
Cardiac Amyloidosis Research
The investigator specializes in studying transthyretin amyloidosis with cardiomyopathy, a progressive cardiac condition. Their research focuses on innovative therapeutic approaches aimed at reducing mortality and improving cardiovascular outcomes in affected patients.
- ATTR Cardiomyopathy Management
- Cardiovascular Event Prevention
- Mortality Risk Reduction
Cardiovascular Disease Prevention
The investigator conducts research in atherosclerotic cardiovascular disease (ASCVD), with particular emphasis on preventive therapies. Their work explores treatments for patients with established vascular disease, focusing on reducing major adverse cardiovascular events.
- Cardiovascular Death Prevention
- Heart Attack Risk Reduction
- Stroke Prevention Strategies
Cardiac Arrhythmia Studies
The investigator explores therapeutic solutions for patients with atrial fibrillation, particularly focusing on high-risk individuals who cannot receive conventional anticoagulation therapy. Their research aims to prevent ischemic events in this vulnerable patient population.
- Stroke Prevention in AF
- Alternative Anticoagulation Approaches
- High-Risk Patient Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.